SCHEMBL31013419

SCHEMBL31013419

O=C1C(=O)N(c2nc3ccccc3o2)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ BCHE P06276 2/20 0.49
▸ CES2 O00748 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ TP53 P04637 1/20 0.44
▸ GABRP O00591 4/20 0.44
▸ GABRD O14764 4/20 0.44
▸ GABRA1 P14867 4/20 0.44
▸ GABRB1 P18505 4/20 0.44
▸ GABRG2 P18507 4/20 0.44
▸ GABRB3 P28472 4/20 0.44
▸ GABRA5 P31644 4/20 0.44
▸ GABRA3 P34903 4/20 0.44
▸ GABRA2 P47869 4/20 0.44
▸ GABRB2 P47870 4/20 0.44
▸ GABRA4 P48169 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21477299 0.77 NPC1 (0.50) ALDH1A1GAANPC1RAB9ATP53
SCHEMBL20908634 0.71 CHRNA7 (0.41) ALDH1A1GAANPSR1NPC1RAB9A
Phenyl Isatin SCHEMBL916808 0.67 CES1 (1.00) CES1ALDH1A1GAABCHECES2
SCHEMBL9465302 0.65 CHRNA7 (0.47) ALDH1A1GAANPSR1NPC1RAB9A
SCHEMBL20908370 0.65 GABRP (0.39) ALDH1A1GAANPC1RAB9ATP53
SCHEMBL11409331 0.65 CES1 (0.58) CES1ALDH1A1GAABCHECES2
SCHEMBL14740730 0.65 ALDH1A1 (0.58) CES1ALDH1A1GAABCHECES2
SCHEMBL2348974 0.65 CES1 (0.73) CES1ALDH1A1GAABCHECES2
SCHEMBL20721761 0.65 CES1 (0.73) CES1ALDH1A1GAABCHECES2
SCHEMBL30596238 0.65 CES1 (0.58) CES1ALDH1A1GAABCHECES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119113101-A Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates 基因泰克公司 2024-12-13 — — CN disclosed
CN-111330017-B Antibody Drug Conjugates (ADCs) that bind 158P1D7 protein 艾更斯司股份有限公司 2024-11-26 — — CN disclosed
CN-118593725-A Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates 基因泰克公司 2024-09-06 — — CN disclosed
CN-118557750-A Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates 基因泰克公司 2024-08-30 — — CN disclosed
Send feedback